Arsenic trioxide at conventional dosage does not aggravate hemorrhage in the first-line treatment of adult acute promyelocytic leukemia.

Wen CuiJin WangRui-Min NieLing-Ling ZhaoMeng-Qing GaoHong-Ming ZhuLi ChenJiong HuJun-Min LiZhi-Xiang ShenZhen-Yi WangSai-Juan ChenZhu ChenKan-Kan WangXiao-Dong XiJian-Qing Mi

Published in: European journal of haematology (2018)

In the first-line treatment of APL, the use of ATO is safe and effective and does not compromise the hemostatic potential that may eventually increase ED rate.

Keyphrases

liver failure
emergency department
respiratory failure
drinking water
acute myeloid leukemia
bone marrow
drug induced
aortic dissection
heavy metals
human health
hepatitis b virus
risk assessment
intensive care unit
young adults